Clinical data | |
---|---|
Trade names | Baxdela, Quofenix, Delabaxi |
Other names | ABT-492; RX-3341; WQ-3034 |
AHFS/Drugs.com | Monograph |
License data |
|
Routes of administration | By mouth, intravenous injection |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C18H12ClF3N4O4 |
Molar mass | 440.76 g·mol−1 |
3D model (JSmol) | |
|
Delafloxacin sold under the brand name Baxdela among others, is a fluoroquinolone antibiotic used to treat acute bacterial skin and skin structure infections.[1]
Baxdela FDA label
was invoked but never defined (see the help page).